On March 15, 2013, Stem Cell Therapeutics Corp. (TSXV: SSS), a life sciences company developing stem cell-related technologies, announced that it had closed its previously announced prospectus offering of units for the aggregate gross proceeds of $3,078,750. Euro Pacific Canada Inc. acted as the agent for the offering.

Gowlings was counsel to Euro Pacific Canada Inc. in this offering with a team that included Vanessa Grant, Anita Nador and Steven Cutler (corporate) and Gloria Geddes (tax), assisted by students-at-law Kelby Carter, Dan King and Matthew Literovich.